Keep up to date with the latest news and information from Medilink West Midlands and our members across the Medical Technology and Life Science sectors, together with topical regional, national and international news.
This week’s OLS Bulletin includes MHRA’s published, first formal regulatory guidance on the post-transition period. This included guidance on Clinical trials, Medical Devices, Licensing, Importing and exporting, IT systems, Pharmacovigilance, and Paediatrics
22nd June 2020
Medilink shares this bulletin with its members and networks, aimed to keep the life sciences sector up to date on the latest guidance whilst the UK is in the transition period and during the Coronavirus (COVID-19) outbreak.
Medilink shares this bulletin with its members and networks, aimed to keep the life sciences sector up to date on the latest guidance whilst the UK is in the transition period and during the Coronavirus (COVID-19) outbreak.
Medilink WM brings you the latest Office for Life Sciences Bulletin.
This bulletin is issued by the Department for Business, Energy and Industrial Strategy and provides the latest information for employers and businesses on coronavirus (COVID-19).
Medilink West Midlands brings you the latest guidance and updates from the Office for Life Sciences.
Medilink West Midlands brings you the latest guidance and updates from the Office for Life Sciences bulletin.
This bulletin aims to keep the life sciences sector up to date on the latest guidance and important information from Government, with a special focus on the Coronavirus (Covid-19).
Special Business Readiness Bulletin – Important Coronavirus (COVID-19) Information for businesses and employers
Welcome to the latest Office for Life Sciences bulletin, aimed at keeping the life sciences sector up to date on the latest guidance. The Office for Life Sciences (OLS) is a joint unit between the Department of Health & Social Care (DHSC) and Department for Business, Energy & Industrial Strategy (BEIS). 20.02.20 Office for Life Sciences Bulletin. If […]